Phase I clinical trial of gemcitabine given as an intravenous bolus on 5 consecutive days.
O'Rourke
T J
TJ
Brown
T D
TD
Havlin
K
K
Kuhn
J G
JG
Craig
J B
JB
Burris
H A
HA
Satterlee
W G
WG
Tarassoff
P G
PG
Von Hoff
D D
DD
D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage*; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D004334:Drug Administration Schedule; D005260:Female; D005334:Fever / Q000139:chemically induced; D006801:Humans; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000188:drug therapy; D000093542:Gemcitabine
D000964:Antimetabolites, Antineoplastic; D003841:Deoxycytidine; D000093542:Gemcitabine